Your browser doesn't support javascript.
loading
Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris.
Kircik, Leon; Del Rosso, James Q; Weiss, Jonathan S; Stakias, Vassilis; London, Anat; Keynan, Rita; Hazot, Yohan; Elliott, Russell; Stuart, Iain.
Afiliación
  • Kircik L; Dr. Kircik is with the Icahn School of Medicine at Mount Sinai in New York, New York.
  • Del Rosso JQ; Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada.
  • Weiss JS; Dr. Weiss is with Georgia Dermatology Partners in Snellville, Georgia.
  • Stakias V; Drs. Stakias, Elliott, and Stuart are with Foamix Pharmaceuticals Inc. in Bridgewater, New Jersey.
  • London A; Dr. London, Ms. Keynan, and Mr. Hazot are with Foamix Pharmaceuticals Ltd in Rehovot, Israel.
  • Keynan R; Dr. Kircik is with the Icahn School of Medicine at Mount Sinai in New York, New York.
  • Hazot Y; Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada.
  • Elliott R; Dr. Weiss is with Georgia Dermatology Partners in Snellville, Georgia.
  • Stuart I; Drs. Stakias, Elliott, and Stuart are with Foamix Pharmaceuticals Inc. in Bridgewater, New Jersey.
J Clin Aesthet Dermatol ; 13(4): 14-21, 2020 Apr.
Article en En | MEDLINE | ID: mdl-33144907
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Aesthet Dermatol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Aesthet Dermatol Año: 2020 Tipo del documento: Article